Latest Rare diseases Stories
NEW YORK, Oct.
TAIPEI, Oct. 21, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc.
- Label expansion to broaden patient base who may benefit from nonsurgical collagenase therapy LYNBROOK, N.Y., Oct.
Estimated 35-40 Percent of Surgical Procedures to Treat DC Have Been Performed on Multiple Joints CHESTERBROOK, Pa., Oct.
Largest retrospective study of its kind reveals that nearly 60 percent of patients with both uveitis and MS are diagnosed with each within a 5-year span CHICAGO, Oct.
HARRISBURG, Pa., Oct.
Proven population-scale platform delivers best results in rare disease and cancer clinical interpretation, as well as secondary analysis and variant refinement CAMBRIDGE, Mass., Oct.
TIMONIUM, Md., Oct.
Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct.
- To swell, as grain or wood with water.